$NIO the promise of PSS with good battery is more than enough to win paying customers. IMHO

77% potential customers end c up buying nio car. Wooooooo

Good for customers ?

It's nice to know that the CEO wants to keep the customers happy though.

Everyone gets their phones out and starts filming, then sharing on social media/sharing with friends and family etc.. Free advertising and brand awareness for NIO and an amazing customer experience for the user.

with a virtually german ride with exceptionsl customer service and beyond.

$NIO new (12min) Fast charger that has $BYD customers as main users definitely will “think” about the NIO SUV & Sedan lineups!

$NIO stop comparing Nio with Tesla.. Tesla cars are nothing as compare to Nio cars.. Tesla services are pathetic and Nio is fully committed to their customers.. Nio will be biggest EV company in 2-3 years..

Oh well, I didn't buy the shares to get rich quick & never invest money which I expect to need for the next 5 years + They have good ideas, beautiful cars & seem to create loyal customers.

These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long term drug stability and increase shelf life for customers in the pharmaceutical segment.

The launch of these products could not come at a better time to support a market that is in demand for products produced in the US that provide speciali zed solutions for customers that need options for their drug-filling operations.

The launch of these products could not come at a better time to support a market that is in demand for products produced in the USA that provide specialized solutions for customers that need options for their drug-filling operations.

The launch of these products could not come at a better time to support a market that is in demand for products produced in the USA that provide specialized solutions for customers that need options for their drug-filling operations.

These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long-term drug stability and increase shelf life for customers in the pharmaceutical segment.

The launch of these products could not come at a better time to support a market that is in demand for products produced in the USA that provide specialized solutions for customers that need options for their drug-filling operations.

as they put out more great news on Europe customers and white label deals this will rocket one day Tuttes fucking with it building positions

These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long term drug stability and increase shelf life for customers in the pharmaceutical segment.

$STSS love the fact 3 deals in play in regards to Hungary vial draw syringes.. European direct customers and another private label for USA market.. That is huge

These new customer projects will fuel the growth of both companies, and the opportunity to create new technologies to support the healthcare industry will be transformative for Nephron and Sharps as they navigate a bright future working together.